Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT04592653 |
Title | Less Frequent IV Dosing & Tumor Microenvironment (TME) Study of Nemvaleukin Alfa (ALKS 4230) Monotherapy and in Combination With Pembrolizumab (ARTISTRY-3) (ARTISTRY-3) |
Acronym | ARTISTRY-3 |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Alkermes, Inc. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | ESP |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Mural Oncology Investigator Site | RECRUITING | Grand Rapids | Michigan | 49546 | United States | Details |
MD Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |
Mural Oncology Investigator Site | RECRUITING | West Valley City | Utah | 84119 | United States | Details |
Mural Oncology Investigator Site | RECRUITING | Fairfax | Virginia | 22031 | United States | Details |
Mural Oncology Investigator Site | RECRUITING | Madrid | 28040 | Spain | Details | |
Mural Oncology Investigator Site | RECRUITING | Madrid | 28050 | Spain | Details |